Azelastine Completed Phase 2 Trials for Rhinitis, Allergic, Seasonal / Allergic Rhinitis (AR) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00612118A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis